Related Experiment Video
Updated: May 24, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Activity of fourteen new hydantoin compounds on the human ABCB1 efflux pump
Ana Martins1, Anna Dymek, Jadwiga Handzlik
1Institute of Pharmacognosy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary.
Background:
Multidrug resistance (MDR) is one of the major concerns in the treatment of cancer and one of the major causes of therapy failure. The overexpression of an ABC transporter, the ABCB1, is often associated with MDR in cancer. Previously it was observed that hydantoin compounds can modulate the activity of the ABCB1 pump.
Materials And Methods:
Fourteen hydantoin derivatives were synthesized and studied for their capacity to increase accumulation of ethidium bromide (EB) by mouse lymphoma cancer cells that were transfected with the human ABCB1 gene and overexpress the human ABCB1 pump.
Results:
It was observed that the accumulation of EB by the cells in the presence of four of the newly synthesized hydantoins was strongly increased. Similar but milder effects were also observed for the other seven hydantoins; the remaining three had no activity.
Conclusion:
The 14 hydantoin compounds studied belong to three different structural groups. Structure-activity relationships were studied and important molecular substituents that were possibly responsible for increased the activity of the molecules were identified. This important information may lead to the continuation of our work and to the future synthesis of more active compounds.
Insights
New hydantoin compounds show promise in overcoming multidrug resistance (MDR) in cancer by modulating ABCB1 transporter activity. This research identifies key structural features for developing more effective cancer therapies.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) is a significant challenge in cancer treatment, often linked to ABCB1 transporter overexpression.
- ABCB1 transporter activity is a key factor in cancer therapy failure.
- Hydantoin compounds have demonstrated potential in modulating ABCB1 pump activity.
Purpose of the Study:
- To synthesize and evaluate novel hydantoin derivatives for their ability to overcome ABCB1-mediated MDR.
- To identify structure-activity relationships among the synthesized hydantoins.
Main Methods:
- Synthesis of fourteen hydantoin derivatives.
- Assay of hydantoin derivatives' capacity to increase ethidium bromide (EB) accumulation in ABCB1-overexpressing mouse lymphoma cancer cells.
Main Results:
- Four hydantoin derivatives significantly increased EB accumulation, indicating potent ABCB1 modulation.
- Seven additional hydantoins showed milder effects, while three were inactive.
- Structure-activity relationship analysis identified key molecular substituents responsible for enhanced activity.
Conclusions:
- The study identified active hydantoin compounds with potential to reverse ABCB1-mediated MDR.
- Structure-activity relationship insights pave the way for designing more potent anticancer agents.
- Further research and synthesis of novel hydantoins are warranted to develop effective MDR-targeting therapies.
More Related Videos
05:06Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Hepatic Drug Clearance: Role of Transporters
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...